|
MechanismH1 receptor antagonists |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date01 Jan 1953 |
100 Clinical Results associated with Guangzhou Baiyunshan Jigong Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guangzhou Baiyunshan Jigong Pharmaceutical Co., Ltd.
100 Deals associated with Guangzhou Baiyunshan Jigong Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guangzhou Baiyunshan Jigong Pharmaceutical Co., Ltd.